Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease

Neurobiol Dis. 2014 May:65:112-23. doi: 10.1016/j.nbd.2014.01.017. Epub 2014 Feb 1.

Abstract

Although the cardinal features of Parkinson's disease (PD) are motor symptoms, PD also causes cognitive deficits including cognitive flexibility and working memory, which are strongly associated with prefrontal cortex (PFC) functions. Yet, early stage PD is not characterized by pathology in the PFC but by a loss of dopaminergic (DA) projections from the substantia nigra to the dorsal striatum. Moreover, the degree to which PD symptoms can be ascribed to the loss of DA alone or to the loss of DA neurons is unknown. We addressed these issues by comparing mouse models of either chronic DA depletion or loss of DA projections to the dorsal striatum. We achieved equal levels of striatal DA reduction in both models which ranged from mild (~25%) to moderate (~60%). Both models displayed DA concentration-dependent reductions of motor function as well as mild deficits of cognitive flexibility and working memory. Interestingly, whereas both motor function and cognitive flexibility were more severely impaired after mild ablation of DA neurons as compared to mild loss of DA alone, both models had equal deficits after moderate loss of DA. Our results confirm contributions of nigro-striatal dopamine signaling to cognitive behaviors that are affected in early stage PD. Furthermore, our findings suggest that the phenotype after ablation of DA neurons accrues from factors beyond the mere loss of DA.

Keywords: 6-Hydroxydopamine; Dopamine-deficient mice; Executive function; Neurodegeneration; Tyrosine hydroxylase; Viral inactivation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cognition Disorders / pathology*
  • Corpus Striatum / pathology*
  • Disease Models, Animal
  • Dopamine / metabolism
  • Dopaminergic Neurons / metabolism*
  • Memory / physiology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Motor Activity / drug effects
  • Motor Activity / genetics
  • Motor Skills Disorders / etiology
  • Muscle Strength / drug effects
  • Muscle Strength / physiology
  • Oxidopamine / toxicity
  • Parkinson Disease / complications*
  • Parkinson Disease / etiology
  • Parkinson Disease / pathology*
  • Psychomotor Performance / physiology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Sympatholytics / toxicity
  • Tyrosine 3-Monooxygenase / deficiency
  • Tyrosine 3-Monooxygenase / genetics

Substances

  • Sympatholytics
  • Oxidopamine
  • Tyrosine 3-Monooxygenase
  • Dopamine